10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2017 | |||
Consolidated Statements of Earnings | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 21, 2018) | |||
(In Millions, except shares in Thousands) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2017 | Jan 1, 2017 | Jan 3, 2016 | |
Sales to customers | $ 76,450 | 71,890 | 70,074 |
Cost of products sold | 25,354 | 21,685 | 21,536 |
Gross profit | 51,096 | 50,205 | 48,538 |
Selling, marketing and administrative expenses | 21,420 | 19,945 | 21,203 |
Research and development expense | 10,554 | 9,095 | 9,046 |
In-process research and development | 408 | 29 | 224 |
Interest income | (385) | (368) | (128) |
Interest expense, net of portion capitalized (Note 4) | 934 | 726 | 552 |
Other (income) expense, net | 183 | 484 | (2,064) |
Restructuring (Note 22) | 309 | 491 | 509 |
Earnings before provision for taxes on income | 17,673 | 19,803 | 19,196 |
Provision for taxes on income (Note 8) | 16,373 | 3,263 | 3,787 |
Net earnings | 1,300 | 16,540 | 15,409 |
Net earnings per share (Notes 1 and 15) | |||
Basic (in dollars per share) | 0.48 | 6.04 | 5.56 |
Diluted (in dollars per share) | 0.47 | 5.93 | 5.48 |
Cash dividends per share (in dollars per share) | 3.32 | 3.15 | 2.95 |
Average shares outstanding (Notes 1 and 15) | |||
Basic (in shares) | 2,692,000 | 2,737,300 | 2,771,800 |
Diluted (in shares) | 2,745,300 | 2,788,900 | 2,812,900 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2017 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 21, 2018) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2017 | Jan 1, 2017 | Jan 3, 2016 | |
Net earnings | $ 1,300 | 16,540 | 15,409 |
Other Comprehensive Income (Loss), net of tax | |||
Foreign currency translation | 1,696 | (612) | (3,632) |
Securities | |||
Unrealized holding gain (loss) arising during period | 159 | (52) | 471 |
Reclassifications to earnings | (338) | (141) | (124) |
Net change | (179) | (193) | 347 |
Employee benefit plans | |||
Prior service credit (cost), net of amortization | 2 | 21 | (60) |
Gain (loss), net of amortization | 29 | (862) | 931 |
Effect of exchange rates | (201) | 159 | 148 |
Net change | (170) | (682) | 1,019 |
Derivatives & hedges | |||
Unrealized gain (loss) arising during period | (4) | (359) | (115) |
Reclassifications to earnings | 359 | 110 | (62) |
Net change | 355 | (249) | (177) |
Other comprehensive income (loss) | 1,702 | (1,736) | (2,443) |
Total comprehensive income | 3,002 | 14,804 | 12,966 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2017 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 21, 2018) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2017 | Jan 1, 2017 | Jan 3, 2016 | |
Net earnings | $ 1,300 | 16,540 | 15,409 |
Cash flows from operating activities | |||
Adjustments to reconcile net earnings to cash flows from operating activities: | |||
Depreciation and amortization of property and intangibles | 5,642 | 3,754 | 3,746 |
Stock based compensation | 962 | 878 | 874 |
Venezuela adjustments | 0 | 0 | 122 |
Asset write-downs | 795 | 283 | 624 |
Net gain on sale of assets/businesses | (1,307) | (563) | (2,583) |
Deferred tax provision | 2,406 | (341) | (270) |
Accounts receivable allowances | 17 | (11) | 18 |
Changes in assets and liabilities, net of effects from acquisitions and divestitures: | |||
Increase in accounts receivable | (633) | (1,065) | (433) |
Decrease/(Increase) in inventories | 581 | (249) | (449) |
Increase in accounts payable and accrued liabilities | 2,725 | 656 | 287 |
Increase in other current and non-current assets | (411) | (529) | (103) |
Increase/(Decrease) in other current and non-current liabilities | 8,979 | (586) | 2,327 |
Net cash flows from operating activities | 21,056 | 18,767 | 19,569 |
Cash flows from investing activities | |||
Additions to property, plant and equipment | (3,279) | (3,226) | (3,463) |
Proceeds from the disposal of assets/businesses, net | 1,832 | 1,267 | 3,464 |
Acquisitions, net of cash acquired (Note 20) | (35,151) | (4,509) | (954) |
Purchases of investments | (6,153) | (33,950) | (40,828) |
Sales of investments | 28,117 | 35,780 | 34,149 |
Other (primarily intangibles) | (234) | (123) | (103) |
Net cash used by investing activities | (14,868) | (4,761) | (7,735) |
Cash flows from financing activities | |||
Dividends to shareholders | (8,943) | (8,621) | (8,173) |
Repurchase of common stock | (6,358) | (8,979) | (5,290) |
Proceeds from short-term debt | 869 | 111 | 2,416 |
Retirement of short-term debt | (1,330) | (2,017) | (1,044) |
Proceeds from long-term debt, net of issuance costs | 8,992 | 12,004 | 75 |
Retirement of long-term debt | (1,777) | (2,223) | (68) |
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net | 1,062 | 1,189 | 1,005 |
Other | (188) | (15) | (57) |
Net cash used by financing activities | (7,673) | (8,551) | (11,136) |
Effect of exchange rate changes on cash and cash equivalents | 337 | (215) | (1,489) |
(Decrease)/Increase in cash and cash equivalents | (1,148) | 5,240 | (791) |
Cash and cash equivalents, beginning of year (Note 1) | 18,972 | 13,732 | |
Cash and cash equivalents, end of year (Note 1) | 17,824 | 18,972 | 13,732 |
Supplemental cash flow data | |||
Interest | 960 | 730 | 617 |
Interest, net of amount capitalized | 866 | 628 | 515 |
Income taxes | 3,312 | 2,843 | 2,865 |
Supplemental schedule of non-cash investing and financing activities | |||
Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards | 2,062 | 2,043 | 1,486 |
Conversion of debt | 16 | 35 | 16 |
Acquisitions | |||
Fair value of assets acquired | 36,937 | 4,586 | 1,174 |
Fair value of liabilities assumed and noncontrolling interests | (1,786) | (77) | (220) |
Net cash paid for acquisitions | 35,151 | 4,509 | 954 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2017 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2017 10-K (Filed: Feb 21, 2018) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2017 | Jan 1, 2017 | |
Assets | ||
Current assets: | ||
Cash and cash equivalents (Notes 1 and 2) | $ 17,824 | 18,972 |
Marketable securities (Notes 1 and 2) | 472 | 22,935 |
Accounts receivable trade, less allowances for doubtful accounts $291 (2016, $252) | 13,490 | 11,699 |
Inventories (Notes 1 and 3) | 8,765 | 8,144 |
Prepaid expenses and other receivables | 2,537 | 3,282 |
Total current assets | 43,088 | 65,032 |
Property, plant and equipment, net (Notes 1 and 4) | 17,005 | 15,912 |
Intangible assets, net (Notes 1 and 5) | 53,228 | 26,876 |
Goodwill (Notes 1 and 5) | 31,906 | 22,805 |
Deferred taxes on income (Note 8) | 7,105 | 6,148 |
Other assets | 4,971 | 4,435 |
Total assets | 157,303 | 141,208 |
Liabilities and Shareholders' Equity | ||
Current liabilities: | ||
Loans and notes payable (Note 7) | 3,906 | 4,684 |
Accounts payable | 7,310 | 6,918 |
Accrued liabilities | 7,304 | 5,635 |
Accrued rebates, returns and promotions | 7,210 | 5,403 |
Accrued compensation and employee related obligations | 2,953 | 2,676 |
Accrued taxes on income (Note 8) | 1,854 | 971 |
Total current liabilities | 30,537 | 26,287 |
Long-term debt (Note 7) | 30,675 | 22,442 |
Deferred taxes on income (Note 8) | 8,368 | 2,910 |
Employee related obligations (Notes 9 and 10) | 10,074 | 9,615 |
Long-term taxes payable (Note 8) | 8,472 | 0 |
Other liabilities | 9,017 | 9,536 |
Total liabilities | 97,143 | 70,790 |
Shareholders' equity: | ||
Preferred stock without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
Common stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
Accumulated other comprehensive income (loss) (Note 13) | (13,199) | (14,901) |
Retained earnings | 101,793 | 110,551 |
Stockholders' Equity before Treasury Stock | 91,714 | 98,770 |
Less: common stock held in treasury, at cost (Note 12) (437,318,000 shares and 413,332,000 shares) | 31,554 | 28,352 |
Total shareholders equity | 60,160 | 70,418 |
Total liabilities and shareholders equity | 157,303 | 141,208 |
External Links | |
JOHNSON & JOHNSON (JNJ) Fiscal Year 2017 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |